MREO vs TSLA · $48.7M cap vs P/E 179, rev $94.83B
Mereo BioPharma Group PLC ADR (MREO) versus Tesla Inc (TSLA) — a side-by-side from cached financials, not a winner call.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
Tesla Inc (TSLA) is a auto manufacturers company listed on US. It is led by Elon R. Musk.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
Latest reported TSLA revenue for 2025-12-31 was $94.83B. Net income was $3.79B. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
MREO currently screens at market cap $48.7M. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
Not investment advice. Open the MREO and TSLA stock pages for the full models.
Not investment advice.